Synthesis of novel antioxidant and antitumor 5-aminopyrazole derivatives, 2D/3D QSAR, and molecular docking

被引:11
|
作者
Fekri, Ahmed [1 ]
Keshk, Eman M. [1 ]
Khalil, Abdel-Galil M. [1 ]
Taha, Israa [1 ]
机构
[1] Mansoura Univ, Fac Sci, Dept Chem, 25 El Gomhouria St, Mansoura 35516, Dakahlia Govern, Egypt
关键词
5-aminopyrazole; SRB assay; Hep-G2; DPPH; ABTS; Bioactivity; MOE; BIOLOGICAL EVALUATION; HEPATOCELLULAR-CARCINOMA; PYRAZOLE DERIVATIVES; ANTIVIRAL EVALUATION; DESIGN; INHIBITORS; TRIAZINES; THIOUREA; AGENTS;
D O I
10.1007/s11030-021-10184-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
5-Aminopyrazole serves as a vital precursor for several biologically active pyrazoloazines, including pyrazolopyridine, pyrazolopyrimidine, and pyrazolotriazine, as well as Schiff bases, thiourea, and phthalimide derivatives. In this study, we structurally characterized novel pyrazole derivatives by spectral IR, H-1 and C-13 NMR, and MASS spectroscopy. We also evaluated antioxidant activity of various derivatives using ABTS and DPPH methods and cytotoxicity in the hepatocellular carcinoma Hep-G2 cells by SRB assay. The most potent antitumor molecules were 5-aminopyrazole derivative 3, chloroacetanilide derivative 8, maleimide derivative 10a, pyrazolopyrimidine 16, and enamine 19, with IC50 values of 41, 3.6, 37, 24.4, and 17.7 mu M, respectively. Complementary computational studies predicted QSAR and bioactivity of these molecules. Interestingly, the most effective compounds were also predicted to be kinase inhibitors; in addition, molecular docking with liver receptors (3MBG, 4XCU, and 4G9C) predicted promising interactions. [GRAPHICS] .
引用
收藏
页码:781 / 800
页数:20
相关论文
共 50 条
  • [1] Synthesis of novel antioxidant and antitumor 5-aminopyrazole derivatives, 2D/3D QSAR, and molecular docking
    Ahmed Fekri
    Eman M. Keshk
    Abdel-Galil M. Khalil
    Israa Taha
    Molecular Diversity, 2022, 26 : 781 - 800
  • [2] MOLECULAR DOCKING, PHARMACOPHORE MODELLING AND 3D QSAR ANALYSIS OF NOVEL CHALCONE DERIVATIVES
    Gandhi, Sahaj A.
    Barot, V. M.
    Patel, M. C.
    Malek, T. J.
    Patel, U. H.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (04): : 1725 - 1733
  • [3] Design, 2D Qsar Studies, Molecular Docking, and Synthesis of Novel Triazole Derivatives intended as an Antifungal Agents
    Yuvarani, K.
    Ramalakshmi, N.
    Arunkumar, S.
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2023, 49 (SUPPL 1) : S202 - S223
  • [4] Design, 2D Qsar Studies, Molecular Docking, and Synthesis of Novel Triazole Derivatives intended as an Antifungal Agents
    K. Yuvarani
    N. Ramalakshmi
    S. Arunkumar
    Russian Journal of Bioorganic Chemistry, 2023, 49 : S202 - S223
  • [5] Pharmacophore mapping, 3D QSAR, molecular docking, and ADME prediction studies of novel Benzothiazinone derivatives
    Jahaan Shaikh
    Salman Patel
    Afzal Nagani
    Moksh Shah
    Siddik Ugharatdar
    Ashish Patel
    Drashti Shah
    Dharti Patel
    In Silico Pharmacology, 12 (2)
  • [6] Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors
    Bhansali, S. G.
    Kulkarni, V. M.
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2014, 25 (11) : 905 - 937
  • [7] Development of 2D and 3D QSAR models of pyrazole derivatives as esterase inhibitors
    Mishra, Puja
    Nandi, Sumit
    Chatterjee, Ankit
    Nayek, Tridib
    Basak, Souvik
    Halder, Amit Kumar
    Mukherjee, Arup
    JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2024, 89 (7-8) : 981 - 995
  • [8] 3D-QSAR and molecular docking for the discovery of ketolide derivatives
    Ruan, Zhi-Xiong
    Huangfu, De-Sheng
    Xu, Xing-Jun
    Sun, Ping-Hua
    Chen, Wei-Min
    EXPERT OPINION ON DRUG DISCOVERY, 2013, 8 (04) : 427 - 444
  • [9] Molecular Docking and 3D QSAR Studies of Chk2 Inhibitors
    Pasha, Fahran Ahmad
    Muddassar, Muhammad
    Cho, Seung Joo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 73 (03) : 292 - 300
  • [10] Design, synthesis, antitumor evaluation, 3D-QSAR and molecular docking studies of novel 4-aminoacridone compounds
    Lin Tian
    Chang J. Feng
    Tong X. Li
    Zhao Li
    Wei H. Yang
    Xiang E. Han
    Medicinal Chemistry Research, 2017, 26 : 2538 - 2546